Bioera S.p.A. (BIE.MI)

EUR 0.04

(0.0%)

Operating Expenses Summary of Bioera S.p.A.

Bioera S.p.A.'s latest annual operating expenses in 2023 was 4.19 Million EUR , up 33.94% from previous year.
Bioera S.p.A.'s latest quarterly operating expenses in 2024 Q2 was 971 Thousand EUR , down -0.92% from previous quarter.
Bioera S.p.A. reported a annual operating expenses of 2.29 Million EUR in annual operating expenses 2022, up 56.02% from previous year.
Bioera S.p.A. reported a annual operating expenses of 1.46 Million EUR in annual operating expenses 2021, down -66.85% from previous year.
Bioera S.p.A. reported a quarterly operating expenses of 980 Thousand EUR for 2023 Q4, up 107.63% from previous quarter.
Bioera S.p.A. reported a quarterly operating expenses of 472 Thousand EUR for 2023 Q2, down -82.72% from previous quarter.

Annual Operating Expenses Chart of Bioera S.p.A. (2023 - 2005)

Historical Annual Operating Expenses of Bioera S.p.A. (2023 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2023	4.19 Million EUR	33.94%
2022	2.29 Million EUR	56.02%
2021	1.46 Million EUR	-66.85%
2020	4.43 Million EUR	-21.79%
2019	5.66 Million EUR	48.2%
2018	3.82 Million EUR	-59.15%
2017	9.36 Million EUR	8.96%
2016	8.59 Million EUR	3.93%
2015	8.26 Million EUR	1.06%
2014	8.17 Million EUR	12.12%
2013	7.29 Million EUR	54.95%
2012	4.7 Million EUR	250.95%
2011	-3.11 Million EUR	-113.72%
2010	22.73 Million EUR	-59.07%
2009	55.55 Million EUR	14.96%
2008	48.32 Million EUR	21.93%
2007	39.63 Million EUR	56.66%
2006	25.3 Million EUR	38.7%
2005	18.24 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	971 Thousand EUR	-0.92%
2023 Q4	980 Thousand EUR	107.63%
2023 Q2	472 Thousand EUR	-82.72%
2023 FY	3.07 Million EUR	33.94%
2022 Q4	2.73 Million EUR	489.85%
2022 FY	2.29 Million EUR	56.02%
2022 Q2	463 Thousand EUR	-68.65%
2021 Q2	659 Thousand EUR	-86.01%
2021 FY	1.46 Million EUR	-66.85%
2021 Q4	1.47 Million EUR	124.13%
2020 Q2	2.44 Million EUR	-57.33%
2020 FY	4.43 Million EUR	-21.79%
2020 Q4	4.7 Million EUR	92.91%
2019 FY	5.66 Million EUR	48.2%
2019 Q4	5.72 Million EUR	19.27%
2019 Q2	4.79 Million EUR	90.09%
2018 Q4	2.52 Million EUR	-33.69%
2018 Q2	3.8 Million EUR	-25.42%
2018 FY	3.82 Million EUR	-59.15%
2017 Q4	5.1 Million EUR	0.41%
2017 FY	9.36 Million EUR	8.96%
2017 Q2	5.08 Million EUR	13.92%
2016 Q4	4.46 Million EUR	-6.05%
2016 FY	8.59 Million EUR	3.93%
2016 Q2	4.74 Million EUR	-6.72%
2015 Q2	4.56 Million EUR	-19.88%
2015 Q4	5.08 Million EUR	11.58%
2015 FY	8.26 Million EUR	1.06%
2014 Q4	5.69 Million EUR	33.61%
2014 Q2	4.26 Million EUR	66.38%
2014 FY	8.17 Million EUR	12.12%
2013 Q2	3.19 Million EUR	0.0%
2013 FY	7.29 Million EUR	54.95%
2013 Q4	2.56 Million EUR	-19.77%
2012 FY	4.7 Million EUR	250.95%
2011 FY	-3.11 Million EUR	-113.72%
2011 Q2	- EUR	0.0%
2010 Q2	- EUR	0.0%
2010 FY	22.73 Million EUR	-59.07%
2009 Q2	- EUR	0.0%
2009 FY	55.55 Million EUR	14.96%
2008 FY	48.32 Million EUR	21.93%
2007 FY	39.63 Million EUR	56.66%
2006 FY	25.3 Million EUR	38.7%
2005 FY	18.24 Million EUR	0.0%

Peer Operating Expenses Comparison of Bioera S.p.A.

Name	Operating Expenses	Operating Expenses Difference
GPI S.p.A.	62.97 Million EUR	93.343%
Poste Italiane S.p.A.	2.6 Billion EUR	99.839%